Polytex India (512481)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹7.78 |
| Market Cap | ₹11.04 Cr |
| P/E Ratio | 0 |
| ROCE | -4.04% |
| ROE | -5.45% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹4.31 — ₹7.78 |
| Sector | Finance |
| Book Value | ₹1.83 |
Strengths
- Positive book value of ₹1.83 per share provides a thin equity cushion and the company is not insolvent.
- Latest quarter net loss is -₹0 Cr, so the company is not burning significant cash at present.
- No dividend outflow conserves whatever capital remains for a possible future revival.
- Debt/Equity is N/A in the given data, so leverage is not a visible source of immediate distress.
Concerns
- Zero sales (₹0 Cr) and zero profit growth mean there is no operating business or earning power.
- ROE is -5.45% and ROCE is -4.04%, showing continuing value destruction on shareholder funds.
- Price of ₹7.78 is 4.25 times book value of ₹1.83, and P/E of 0.00 is meaningless because there are no earnings.
- Piotroski F-Score of 2/9 and zero dividend indicate poor financial health and no reward to shareholders.
AI Analysis
Friends, when I look at Polytex India, I don't see a business—I see a financial shell. This NBFC reports sales of ₹0 Cr and a latest quarter net profit of -₹0 Cr. There is no earnings stream to analyse. No revenue means no customers, no pricing power, no moat. A Buffett-style purchase requires a franchise with durable competitive advantage; Polytex has none. At ₹11 Cr market cap, this is a micro-cap, but small size is not a shield. The financial health is weak. Return on equity is -5.45% and ROCE is -4.04%, so every rupee retained is earning less than nothing. The Piotroski F-Score is 2 out of 9, which confirms distress. Book value is ₹1.83 per share, so the company is not insolvent. But the market asks ₹7.78 per share, or 4.25 times book. The P/E of 0.00 is not a bargain—it only shows there are no earnings to put a multiple on. I would rather buy a good company at a fair price than a no-earnings company at a premium to book. Growth is absent: sales growth is 0.00%, profit growth is 0.00%, and there is no dividend. The 52-week range ₹3.70 to ₹7.78 simply reflects speculation, not compounding. Debt/Equity is N/A, but without profit, leverage is not the main worry—lack of earning power is. This may be a turnaround candidate if management brings in a real loan book and positive returns. Until then, Graham's lesson applies: price is what you pay, value is what you get. Here, the value is unproven. The only sensible move for a value investor is to wait on the sidelines until Polytex shows positive earnings, a higher return on equity, or a price below tangible book. This is not an investment; it is a lottery ticket.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer